219 related articles for article (PubMed ID: 27422057)
1. Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells.
Li M; Zhao H; Ananiev GE; Musser MT; Ness KH; Maglaque DL; Saha K; Bhattacharyya A; Zhao X
Stem Cells; 2017 Jan; 35(1):158-169. PubMed ID: 27422057
[TBL] [Abstract][Full Text] [Related]
2. High Throughput Small Molecule Screen for Reactivation of
Hunt JFV; Li M; Risgaard R; Ananiev GE; Wildman S; Zhang F; Bugni TS; Zhao X; Bhattacharyya A
Cells; 2021 Dec; 11(1):. PubMed ID: 35011630
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Screening Using iPSC-Derived Neuronal Progenitors to Identify Compounds Counteracting Epigenetic Gene Silencing in Fragile X Syndrome.
Kaufmann M; Schuffenhauer A; Fruh I; Klein J; Thiemeyer A; Rigo P; Gomez-Mancilla B; Heidinger-Millot V; Bouwmeester T; Schopfer U; Mueller M; Fodor BD; Cobos-Correa A
J Biomol Screen; 2015 Oct; 20(9):1101-11. PubMed ID: 26024946
[TBL] [Abstract][Full Text] [Related]
5. CGG-repeat dynamics and
Zhou Y; Kumari D; Sciascia N; Usdin K
Mol Autism; 2016; 7():42. PubMed ID: 27713816
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells.
Kumari D; Swaroop M; Southall N; Huang W; Zheng W; Usdin K
Stem Cells Transl Med; 2015 Jul; 4(7):800-8. PubMed ID: 25999519
[TBL] [Abstract][Full Text] [Related]
7. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
Li M; Hunt JFVS; Bhattacharyya A; Zhao X
Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
[TBL] [Abstract][Full Text] [Related]
8. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
[TBL] [Abstract][Full Text] [Related]
9. Human pluripotent stem cell models of Fragile X syndrome.
Bhattacharyya A; Zhao X
Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
[TBL] [Abstract][Full Text] [Related]
11. Identification of FMR1-regulated molecular networks in human neurodevelopment.
Li M; Shin J; Risgaard RD; Parries MJ; Wang J; Chasman D; Liu S; Roy S; Bhattacharyya A; Zhao X
Genome Res; 2020 Mar; 30(3):361-374. PubMed ID: 32179589
[TBL] [Abstract][Full Text] [Related]
12. Loss of the fragile X mental retardation protein causes aberrant differentiation in human neural progenitor cells.
Sunamura N; Iwashita S; Enomoto K; Kadoshima T; Isono F
Sci Rep; 2018 Aug; 8(1):11585. PubMed ID: 30072797
[TBL] [Abstract][Full Text] [Related]
13. FMR1 loss in a human stem cell model reveals early changes to intrinsic membrane excitability.
Susco SG; Arias-García MA; López-Huerta VG; Beccard A; Bara AM; Moffitt J; Korn J; Fu Z; Barrett LE
Dev Biol; 2020 Dec; 468(1-2):93-100. PubMed ID: 32976839
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
Gerhardt J
Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
[TBL] [Abstract][Full Text] [Related]
15. Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation.
Lu P; Chen X; Feng Y; Zeng Q; Jiang C; Zhu X; Fan G; Xue Z
Sci China Life Sci; 2016 Nov; 59(11):1093-1105. PubMed ID: 27730449
[TBL] [Abstract][Full Text] [Related]
16. Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons.
Graef JD; Wu H; Ng C; Sun C; Villegas V; Qadir D; Jesseman K; Warren ST; Jaenisch R; Cacace A; Wallace O
Eur J Neurosci; 2020 May; 51(10):2143-2157. PubMed ID: 31880363
[TBL] [Abstract][Full Text] [Related]
17. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
Sølvsten C; Nielsen AL
Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
[TBL] [Abstract][Full Text] [Related]
18. The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling.
Zhang Z; Marro SG; Zhang Y; Arendt KL; Patzke C; Zhou B; Fair T; Yang N; Südhof TC; Wernig M; Chen L
Sci Transl Med; 2018 Aug; 10(452):. PubMed ID: 30068571
[TBL] [Abstract][Full Text] [Related]
19. A 3' untranslated region variant in FMR1 eliminates neuronal activity-dependent translation of FMRP by disrupting binding of the RNA-binding protein HuR.
Suhl JA; Muddashetty RS; Anderson BR; Ifrim MF; Visootsak J; Bassell GJ; Warren ST
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6553-61. PubMed ID: 26554012
[TBL] [Abstract][Full Text] [Related]
20. Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis.
Khalfallah O; Jarjat M; Davidovic L; Nottet N; Cestèle S; Mantegazza M; Bardoni B
Stem Cells; 2017 Feb; 35(2):374-385. PubMed ID: 27664080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]